These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23839185)

  • 41. Rituximab in refractory autoimmune bullous diseases.
    Schmidt E; Hunzelmann N; Zillikens D; Bröcker EB; Goebeler M
    Clin Exp Dermatol; 2006 Jul; 31(4):503-8. PubMed ID: 16716150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early-onset neutropenia after rituximab therapy for bullous pemphigoid.
    Adler BL; Crew AB; Woodley DT
    Clin Exp Dermatol; 2019 Apr; 44(3):334-336. PubMed ID: 30151931
    [No Abstract]   [Full Text] [Related]  

  • 43. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.
    Ferri C; Cacoub P; Mazzaro C; Roccatello D; Scaini P; Sebastiani M; Tavoni A; Zignego AL; De Vita S
    Autoimmun Rev; 2011 Nov; 11(1):48-55. PubMed ID: 21821153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preliminary analysis of mortality associated with rituximab use in autoimmune diseases.
    Shetty S; Ahmed AR
    Autoimmunity; 2013 Dec; 46(8):487-96. PubMed ID: 24151854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases.
    Kasperkiewicz M; Eming R; Behzad M; Hunzelmann N; Meurer M; Schulze-Koops H; von Wussow P; Hertl M; Zillikens D; Freivogel K; Dörner T; Schmidt E
    J Dtsch Dermatol Ges; 2012 Oct; 10(10):727-32. PubMed ID: 22577946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease.
    Li Y; Foshee JB; Sontheimer RD
    J Am Acad Dermatol; 2011 Apr; 64(4):773-8. PubMed ID: 20494477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical outcome and safety of rituximab therapy for pemphigoid diseases.
    Tovanabutra N; Payne AS
    J Am Acad Dermatol; 2020 May; 82(5):1237-1239. PubMed ID: 31738960
    [No Abstract]   [Full Text] [Related]  

  • 48. Rituximab therapy in patients with bullous pemphigoid: A retrospective study of 20 patients.
    Polansky M; Eisenstadt R; DeGrazia T; Zhao X; Liu Y; Feldman R
    J Am Acad Dermatol; 2019 Jul; 81(1):179-186. PubMed ID: 30923002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single dose of rituximab for pediatric-onset refractory systemic lupus erythematosus.
    Ikeda F; Watanabe S; Aizawa-Yashiro T; Tsuruga K; Ito E; Tanaka H
    Lupus; 2013 Dec; 22(14):1541-3. PubMed ID: 23966305
    [No Abstract]   [Full Text] [Related]  

  • 50. Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study.
    Fernández-Nebro A; de la Fuente JL; Carreño L; Izquierdo MG; Tomero E; Rúa-Figueroa I; Hernández-Cruz BE; Narváez J; Ucar E; Olivé A; Zea A; Fernández-Castro M; Raya-Álvarez E; Pego-Reigosa JM; Freire M; Martínez-Taboada VM; Pérez-Venegas J; Sánchez-Atrio AI; Villa-Blanco I; Manrique-Arija S; López-Longo FJ; Carreira PE; Martínez-Pérez R; García-Vicuña R
    Lupus; 2012 Sep; 21(10):1063-76. PubMed ID: 22786985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new approach on bullous pemphigoid therapy.
    Saouli Z; Papadopoulos A; Kaiafa G; Girtovitis F; Kontoninas Z
    Ann Oncol; 2008 Apr; 19(4):825-6. PubMed ID: 18325915
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults.
    Takei T; Itabashi M; Moriyama T; Kojima C; Shiohira S; Shimizu A; Tsuruta Y; Ochi A; Amemiya N; Mochizuki T; Uchida K; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2013 May; 28(5):1225-32. PubMed ID: 23239834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infantile Bullous Pemphigoid Treated Using Intravenous Immunoglobulin: Case Report and Review of the Literature.
    Tekin B; Yücelten AD
    Pediatr Dermatol; 2015; 32(5):723-6. PubMed ID: 26119800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relevance of rituximab therapy in pemphigus vulgaris: analysis of current data and the immunologic basis for its observed responses.
    Feldman RJ; Ahmed AR
    Expert Rev Clin Immunol; 2011 Jul; 7(4):529-41. PubMed ID: 21790294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adjuvant rituximab in the treatment of pemphigus vulgaris: a phase II clinical trial.
    Balighi K; Daneshpazhooh M; Khezri S; Mahdavi-nia M; Hajiseyed-javadi M; Chams-Davatchi C
    Int J Dermatol; 2013 Jul; 52(7):862-7. PubMed ID: 23789604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rituximab in autoimmune bullous diseases: mixed responses and adverse effects.
    Schmidt E; Seitz CS; Benoit S; Bröcker EB; Goebeler M
    Br J Dermatol; 2007 Feb; 156(2):352-6. PubMed ID: 17223877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia.
    Otremba MD; Adam SI; Price CC; Hohuan D; Kveton JF
    Am J Otolaryngol; 2012; 33(5):619-22. PubMed ID: 22361345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.
    Jovancevic B; Lindholm C; Pullerits R
    Lupus; 2013 Jun; 22(7):664-74. PubMed ID: 23612795
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
    Kisner T; Burst V; Teschner S; Benzing T; Kurschat CE
    Nephron Clin Pract; 2012; 120(2):c79-85. PubMed ID: 22286071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review.
    Cao P; Xu W; Zhang L
    Front Immunol; 2022; 13():928621. PubMed ID: 35769474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.